4 JHU professors received the Bisciotti Foundation Translational Fund's first grants - Technical.ly Baltimore

Sciences

Mar. 8, 2019 2:02 pm

4 JHU professors received the Bisciotti Foundation Translational Fund’s first grants

The fund is designed to support research efforts that are on a path to commercialization.

Inside Johns Hopkins' FastForward 1812.

(Photo by Stephen Babcock)

Four Johns Hopkins University professors are receiving support for research through a new fund designed to support discoveries on a path toward commercialization.

The Bisciotti Foundation Translational Fund, created with suppbiort from the foundation started by Baltimore Ravens owner and Aerotek/Allegis Group founder Stephen Bisciotti and his wife Renee, is providing $300,000 annually. Awards range from $25,000 to $100,000, and work is completed over nine months.

Johns Hopkins Tech Ventures (JHTV) received 17 applications, and finalists presented work to an outside panel.

“We were pleased with the diverse set of technologies represented among the applicants and awardees, from solar cells to surgical tools to cancer therapies,” says Nina Urban, associate director of FastForward, JHTV’s startup program. “This represents the breadth and depth of Hopkins innovation.”

Here’s a quick look at the recipients, per JHTV:

  • Susanna Thon, assistant professor of electrical and computer engineering, created concentrators for next-generation solar cells that are designed to make solar energy cheaper and more widely deployable. They maximize light output in these new kinds of solar cells.
  • Edward James Wright III, chief of urology at Johns Hopkins Bayview Medical Center, is developing a disposable medical device to repair a urethral stricture without invasive surgery, according to JHTV.
  • Warren Grayson, associate professor in JHU’s department of biomedical engineering, is creating a new way to repair facial bone loss from cancer using stem cells and 3D-printed scaffolds.
  • Tian-Li Wang, a professor of pathology, oncology and gynecology/obstetrics, is developing a molecule that can treat ovarian cancer.

The fund is a sign of more resources being made available for commercialization activities among JHU faculty at both the university and medical centers. With the school’s stature as a top research university, officials are making a push to create more startups to take those discoveries to market.

Advertisement

Companies: Johns Hopkins
-30-
JOIN THE COMMUNITY, BECOME A MEMBER
Already a member? Sign in here

Advertisement

Vixiar Medical raises $1.5M, reports progress on heart failure monitoring device

BurnAlong raises $1.5M, moves to new offices in Pikesville

Cool talk alert: Informationart founder Lisa Strausfeld is coming to MICA next week

SPONSORED

Baltimore

At 14 West, only go-getters need apply

Baltimore, MD

SmartLogic

Product Designer

Apply Now
Baltimore, MD 21201

Agora Financial

Jr. Project Manager / Business Analyst

Apply Now
Baltimore, MD

SmartLogic

Developer

Apply Now

How Grassroots DesignFest lent collaborative, creative expertise to Baltimore nonprofits

Contrast Security raises $65 million in Series D funding

UMB debuting master’s program in health and social innovation this fall

SPONSORED

Baltimore

Learn to lead digital transformation at Phorum 2019

Baltimore

Mindgrub

Automation Engineer

Apply Now
1629 Thames Street Suite 400 Baltimore, MD 21231

Contrast Security

Software Engineer Java

Apply Now
1629 Thames Street, Suite 400 Baltimore, MD 21231

Contrast Security

Software Engineer Ruby

Apply Now

Sign-up for daily news updates from Technical.ly Baltimore

Do NOT follow this link or you will be banned from the site!